SA

Sumner Anderson

Partner at Deerfield Management

New York, New York

Overview

Work Experience

  • Partner

    2012 - Current

    Pharmaceutical Analyst

  • Critical Mass Partners, Analyst

    2011 - 2012

    Part of a team responsible for managing a healthcare equity long / short fund with $800mm in capital.

  • PioneerPath, Analyst

    2010 - 2011

    PioneerPath Capital is an affiliate of Citadel Investment Group. Part of a team responsible for managing a healthcare equity long / short fund with >$800mm in capital.

  • Managing Director, Investment Banking, Healthcare Group

    2009 - 2010

    Responsible for pharmaceutical, specialty pharmaceutical, generics and biotechnology investment banking across the combined Wachovia / Wells Fargo platform - the third largest U.S. bank by market capitalization.

  • General Partner, Portfolio Manager

    2009 - 2009

    Founded a healthcare equity long / short fund focused on all healthcare sectors. Incorporated in the State of Delaware on May 4, 2009. Maintained close ties to coverage names and sectors. Closed fund to accept position at Wells Fargo Securities.

  • Global Equities Healthcare Group, Pharmaceutical Analyst

    2005 - 2008

    Managed a $600 million healthcare portfolio focused on U.S. and European pharmaceutical, specialty pharmaceutical and generics sectors within a beta-neutral, Global Equities Group. Responsible for idea generation, portfolio construction, trading execution and portfolio risk management within the pharmaceutical, specialty pharmaceutical and generic sectors. Increased responsibility while at Citadel by expanding role from specialty pharmaceutical analyst in 2006 to managing the Global Equities Healthcare Pharmaceutical portfolio in 2008. Built extensive network of management, industry, buy-side and sell-side relationships within healthcare.

  • Principal, Investment Banking, Healthcare Group

    2000 - 2005

    Broad based coverage across entire healthcare sector including pharmaceuticals, biotechnology, medical device and healthcare IT / services sectors. Extensive client relationships built from meeting or working with over 400 public and private companies. Responsibilities included the following: Client calling and execution of M&A, IPO, FO, PIPE, Private Placement and Convertible equity transactions. Leader of the joint TWP / Nomura U.S. / Japanese pharmaceutical calling effort. Significant healthcare private equity experience including evaluating, structuring and negotiating deals.

  • Associate, Investment Banking

    1998 - 2000

Relevant Websites